Biogen
Biogen is a leading biotechnology company focused on discovering, developing, and delivering innovative therapies for neurological and neurodegenerative diseases. With a strong commitment to scientific excellence and patient-centric solutions, Biogen specializes in areas such as multiple sclerosis, Alzheimer’s disease, spinal muscular atrophy, and other serious neurological conditions. The company leverages advanced research and development capabilities to address unmet medical needs and improve patient outcomes worldwide. Biogen’s portfolio includes a range of approved therapies and a robust pipeline of investigational drugs, reflecting its dedication to advancing neuroscience. Through strategic collaborations and a focus on responsible innovation, Biogen continues to drive progress in biotechnology and healthcare.
